• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol-South Tyrol-Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Glucocorticoid apoptosis in childhood lymphoblastic leukemia

Glucocorticoid apoptosis in childhood lymphoblastic leukemia

Reinhard Kofler (ORCID: )
  • Grant DOI 10.55776/P18571
  • Funding program Principal Investigator Projects
  • Status ended
  • Start December 1, 2005
  • End March 31, 2009
  • Funding amount € 202,356
  • Project website

Disciplines

Medical-Theoretical Sciences, Pharmacy (80%); Medical Biotechnology (20%)

Keywords

    Glucocorticoid, Functional gene analysis, Aute lymphoblastic leukemia, Lentiviral expression system, Apoptosis, RNA interfernce

Abstract Final report

Glucocorticoid (GC) - induced apoptosis is a central component in the therapy of acute lymphoblastic leukemia (ALL), and defining its molecular basis and that of GC resistance is crucial for therapeutic improvements. Previously, our laboratory and others have delineated numerous GC-regulated candidate genes in experimental systems (leukemia lines and mouse thymocytes). Very recently, we have exploited a whole genome comparative expression profiling screen to identify genes regulated in lymphoblasts from children with ALL under GC mono- therapy. This study has essentially ruled out several model-based hypotheses and identified a small number of new candidates that now need to be investigated with regard to their functional role in apoptosis induction. For this purpose, we have developed lentiviral expression systems that allow conditional (i.e., tetracycline-regulated) gene over-expression and gene knock-down by RNA interference (RNAi) with small hairpin RNAs. These systems were designed to be "Gateway compatible" (i.e., allowing quick subcloning by highly efficient recombinatorial processes) and, hence, enable functional analyses of several candidate genes within a reasonable time. Regarding biologic systems for these analyses, we have established childhood ALL derived cell lines with constitutive expression of tetracycline-responsive transactivators and/or transrepressors. Since lentiviral constructs have a high transduction efficiency and do not require cell cycle progression for integration into the host genome, the corresponding systems may also be suitable for studies in primary lymphoblasts from patients. Combining these systems, we propose to delineate the functional role of the most promising GC-regulated candidate genes derived from the above mentioned screen both individually or in combinations of two to several genes. In conclusion, the proposed research may considerably improve our understanding of the clinically important anti-leukemic effects of GC.

Glucocorticoid (GC) - induced apoptosis is a central component in the therapy of acute lymphoblastic leukemia (ALL), and defining its molecular basis and that of GC resistance is crucial for therapeutic improvements. Our laboratory and others have delineated, and are still identifying, GC-regulated candidate genes in experimental systems (leukemia cell lines and mouse thymocytes) and, more importantly, in lymphoblasts from children with ALL under GC mono-therapy. Central aim of this project was to investigate the functional role of the most promising candidate genes in apoptosis induction. For this purpose, we developed lentiviral expression systems for conditional (i.e., tetracycline-regulated) gene over-expression and/or gene knock-down by RNA interference with small hairpin RNAs for NR3C1/GR (the GC receptor), PFKFB2 (2 splice variants), ZBTB16, SLA, SOCS1, SNF1LK/SIK1, TSC22D3/GILZ and RGS18 (a candidate gene for GC resistance identified in this project). Using these constructs, we analyzed the functional role of the corresponding genes in childhood ALL derived cell lines (CCRF-CEM, NALM6, PreB697). In one instance (SIK1) a corresponding knock-out mouse was generated in collaboration with J. Penninger in Vienna. With the exception of the GR, which turned out to be a crucial determinator for sensitivity and kinetics of GC-induced apoptosis, none of these candidates appeared to be an essential player in the anti-leukemic GC effects. Thus, at the current state, regulation of components of the large BCL2 family (a family of apoptosis regulating proteins that we investigated mainly in a parallel project), seems to be the most critical event for cell death induction. Some of the `top candidates` seem to play a modulatory role, such as the PFKFB2 splice variant 15B that sensitized cells for apoptosis induction, or ZBTB16 that had a protective effect. Other GC-regulated genes may account for other GC effects such as SLA that might be a critical player in the immunosuppressive action of GC. The constructs, cell lines and knock-out mice generated in the course of this project will be extremely useful for corresponding analyses.

Research institution(s)
  • Medizinische Universität Innsbruck - 100%

Research Output

  • 689 Citations
  • 9 Publications
Publications
  • 2007
    Title The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia
    DOI 10.1038/sj.leu.2405039
    Type Journal Article
    Author Ploner C
    Journal Leukemia
    Pages 370-377
    Link Publication
  • 2007
    Title Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor
    DOI 10.1677/jme.1.02183
    Type Journal Article
    Author Presul E
    Journal Journal of Molecular Endocrinology
    Pages 79-90
    Link Publication
  • 2006
    Title Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor
    DOI 10.1096/fj.06-6214fje
    Type Journal Article
    Author Schmidt S
    Journal The FASEB Journal
    Pages 2600-2602
  • 2006
    Title A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes
    DOI 10.1158/1535-7163.mct-05-0500
    Type Journal Article
    Author Ausserlechner M
    Journal Molecular Cancer Therapeutics
    Pages 1927-1934
    Link Publication
  • 2009
    Title Erratum: Levels of glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis
    DOI 10.1038/leu.2009.35
    Type Journal Article
    Author Gruber G
    Journal Leukemia
    Pages 827-827
  • 2009
    Title Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia
    DOI 10.1016/j.leukres.2009.06.029
    Type Journal Article
    Author Mansha M
    Journal Leukemia Research
    Pages 529-534
  • 2009
    Title Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
    DOI 10.1038/leu.2008.370
    Type Journal Article
    Author Rainer J
    Journal Leukemia
    Pages 746-752
  • 2009
    Title Levels of glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis
    DOI 10.1038/leu.2008.360
    Type Journal Article
    Author Gruber G
    Journal Leukemia
    Pages 820-823
  • 2008
    Title Noxa: at the tip of the balance between life and death
    DOI 10.1038/onc.2009.46
    Type Journal Article
    Author Ploner C
    Journal Oncogene
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF